This is unpublished

Jennifer E.
Adair
Ph.D.

she, her, hers
Physician & Research Faculty
Pinned
Academic
Associate Member, Clinical Research Division, Fred Hutchinson Cancer Research Center
Fleischauer Family Endowed Chair in Gene Therapy Translation, Fred Hutch
Research Associate Professor, Division of Medical Oncology, University of Washington

Photo: Fred Hutch

Education, Training, Board Certifications

Ph.D., Washington State University

Expertise

Gene therapy 

Affiliations  

Fred Hutchinson Cancer Research Center 

Publications

 

Research and/or clinical interests

Dr. Jennifer Adair is developing gene therapies that safely fine-tune the DNA sequences of blood stem cells to treat genetic disorders, HIV and cancers. Her goal is to develop safe, cost-effective and clinically relevant applications for gene therapy that can be implemented worldwide. To help reach this goal, Dr. Adair’s team developed a technology for portable gene therapy. Lab tests show the technology can produce genetically modified blood stem cells that are at least as good as those manufactured in highly specialized clean rooms, requiring less than half the staff. More recently, Dr. Adair developed a nanoparticle to deliver very precise DNA edits into blood stem cells. This technology greatly simplifies delivery of gene therapy and could pave the way for global availability. Dr. Adair also develops techniques to track and count genetically altered cells in living bodies. Tracking provides valuable information for understanding and improving gene therapies.